Get started
Author

Bernd Schweikert

Observed names: B Schweikert, B. SCHWEIKERT, B. Schweikert, Bernd Schweikert Msc, Schweikert, Bernd
Observed institutions: Universität Ulm, Helmholtz Munich, Imperial Consultants, ICON PLC (Ireland), Münchner Zentrum für Gesundheitswissenschaften, Ludwig-Maximilians-Universität München
ORCID: 0000-0001-8253-509X
Observed ORCID: 0000-0001-8253-509X
OpenAlex ID: A5065938776
Costs of back pain in Germany
2008 · Christina M. Wenig, Carsten O. Schmidt, et al. · European Journal of Pain · 436
Empirische Bewertungssätze in der gesundheitsökonomischen Evaluation - ein Vorschlag der AG Methoden der gesundheitsökonomischen Evaluation (AG MEG)
2005 · C Krauth, F Hessel, et al. · Das Gesundheitswesen · 232
Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study
1986 · G. KAHALY, J. SCHREZENMEIR, et al. · European Journal of Clinical Investigation · 201
Validation of the EuroQol questionnaire in cardiac rehabilitation
2005 · B Schweikert, H Hahmann, et al. · Heart · 170
PDF
Quality of life several years after myocardial infarction: comparing the MONICA/KORA registry to the general population
2008 · B. Schweikert, M. Hunger, et al. · European Heart Journal · 143
Modelling the prevalence and cost of back pain with neuropathic components in the general population
2009 · Carsten O. Schmidt, Bernd Schweikert, et al. · European Journal of Pain · 100
Effectiveness and cost-effectiveness of adding a cognitive behavioral treatment to the rehabilitation of chronic low back pain.
2006 · Bernd Schweikert, Eckart Jacobi, et al. · PubMed · 77
Supportive strategies to improve adherence to IFN beta-1b in Multiple Sclerosis — Results of the BetaPlus observational cohort study
2011 · Carlo Pozzilli, Bernd Schweikert, et al. · Journal of the Neurological Sciences · 63
Stellungnahme der AG Methoden der gesundheitsökonomischen Evaluation (AG MEG) zu dem Methodenpapier „Methodik für die Bewertung von Verhältnissen zwischen Nutzen und Kosten im System der deutschen gesetzlichen Krankenversicherung“ des Instituts für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
2008 · C. Krauth, J. John, et al. · Das Gesundheitswesen · 60
1243P Pathologic response as early endpoint for survival following neoadjuvant therapy (NEO-AT) in resectable non-small cell lung cancer (rNSCLC): Systematic literature review and meta-analysis
2020 · N.A. Waser, A. Adam, et al. · Annals of Oncology · 50
PDF
Osteoporotic fractures and subsequent fractures: imminent fracture risk from an analysis of German real-world claims data
2021 · Peyman Hadji, Bernd Schweikert, et al. · Archives of Gynecology and Obstetrics · 34
PDF
Long-term cost-effectiveness of donepezil for the treatment of Alzheimer’s disease
2007 · Stefan J. Teipel, Michael Ewers, et al. · European Archives of Psychiatry and Clinical Neuroscience · 33
Quality of life and depression in multiple sclerosis patients: longitudinal results of the BetaPlus study
2012 · Carlo Pozzilli, Bernd Schweikert, et al. · Journal of Neurology · 32
Intervention study shows outpatient cardiac rehabilitation to be economically at least as attractive as inpatient rehabilitation
2009 · Bernd Schweikert, Harry Hahmann, et al. · Clinical Research in Cardiology · 29
Gesundheitszustand bei Erwachsenen in Deutschland: Ergebnisse einer repräsentativen Befragung mit dem EuroQol 5D (EQ-5D)
2009 · A. Mielck, M. Vogelmann, et al. · Das Gesundheitswesen · 29
Disease management programmes for patients with coronary heart disease—An empirical study of German programmes
2008 · Oliver Gapp, Bernd Schweikert, et al. · Health Policy · 28
Pathological response in resectable non–small cell lung cancer: a systematic literature review and meta-analysis
2024 · Nathalie A Waser, Melanie Quintana, et al. · JNCI Cancer Spectrum · 25
Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries
2014 · Bernd Schweikert, David Pittrow, et al. · BMC Health Services Research · 25
PDF
Development and first assessment of a questionnaire for health care utilization and costs for cardiac patients
2008 · Bernd Schweikert, Harry Hahmann, et al. · BMC Health Services Research · 21
PDF
Long term effects of comprehensive cardiac rehabilitation in an inpatient and outpatient setting.
2011 · Juergen M Steinacker, Yuefei Liu, et al. · PubMed · 15
Gesundheitsökonomische Evaluation von Rehabilitationsprogrammen im Förderschwerpunkt Rehabilitationswissenschaften
2005 · C. Krauth, F. Hessel, et al. · Die Rehabilitation · 15
Assessing quality of life in a clinical study on heart rehabilitation patients: how well do value sets based on given or experienced health states reflect patients’ valuations?
2016 · Reiner Leidl, Bernd Schweikert, et al. · Health and Quality of Life Outcomes · 13
PDF
mpact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review
2022 · Karen Yee, David Alexanderian, et al. · Journal of health economics and outcomes research · 11
Long term effects of comprehensive cardiac rehabilitation in an inpatient and outpatient setting
2011 · JM Steinacker, Y Liu, et al. · Swiss Medical Weekly · 11
Time Trends in Type 2 Diabetes Patients’ Disease Management and Outcomes: Evidence from Two KORA Surveys in Germany
2008 · M. Schunk, B. Schweikert, et al. · Experimental and Clinical Endocrinology & Diabetes · 11
Works count: 79
Citation count: 1,932
H-index: 19
I10-index: 26
Year
Topic
Type